F
Fennec Pharmaceuticals Inc. (FENC)
NCM – Real Time Price. Currency in USD
11.02
+0.47 (4.45%)
At close: Jun 26, 2026, 4:00 PM EDT
11.02
+0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
11.02
+0.47 (4.45%)
At close: Jun 26, 2026, 4:00 PM EDT
11.02
+0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
No Data
There are no news for this stock.
Cash reserves $40.2M barely cover the upcoming debt maturities $0.0
Total current assets $66.9M exceed Total current liabilities $9.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-17.0x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $2.4M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.98 | 6.05 | 10 | |
| Quick ratio | 6.78 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | -17.00 | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 2M | 21M | 48M | 45M | 51M |
| Gross Profit | 1M | 20M | 44M | 41M | 47M |
| Operating Income | -23M | -13M | 3M | -6M | -6M |
| Net Income | -24M | -16M | -436K | -10M | -9M |
| EBITDA | -23M | -13M | 3M | -6M | -6M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 69.78 | 116.88 | 10 |
| Next quarter | 49.26 | 585.72 | 10 |
| Current year | 53.41 | 175.1 | 10 |
| Next year | 49.79 | 284.78 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 9.66 | 103.91 | 105.88 | 130.34 | 9.0 |
| Y/Y | 72.64 | 117.25 | 125 | 155.09 | 10 |
| 3y average | 467.37 | -668.17 | 377.44 | 36.34 | 7.8 |
| 5y average | 460.22 | -407.4 | 221.97 | 18.17 | 7.5 |
| Weighted average score | 8.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |